Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics…
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics…
Mary Zutter, MD, to share Vanderbilt’s lessons learned in assembling resources, selecting disease targets, and engaging physicians in precision medicine pursuits…
Olivier Elemento, PhD, to share what whole exome sequencing, whole genome sequencing, and artificial intelligence will mean to medicine and patient care…
It’s been a little more than a year since Geisinger launched its National Precision Health Initiative, a first-of-its kind unit designed to advance the promise of anticipatory medicine at Geisinger and at healthcare systems throughout the United States…
Prominent health networks/hospitals participate in NIH genetic research supported by more than one billion dollars in funding from the federal government…
Hospitals and healthcare systems increasingly using genomic profiling must integrate it into all facets of care delivery, not just add it to patients’ EHRs…
When a health network CEO considers how to introduce a precision medicine service into clinical care, the up-front costs can be substantial, but the potential rewards are significant …